Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

The H&M group’s sales development in the first quarter 2019

In the first quarter of 2019, i.e. during the period 1 December 2018 to 28 February 2019, the H&M group’s net sales increased by 10 percent and amounted to SEK 51,015 m (46,181). In local currencies, net sales increased by 4 percent. The three-month report to be published on 29 March 2019The three-month report, covering the period 1 December 2018 – 28 February 2019 will be published at 08:00 CET on 29 March 2019. A telephone conference for the financial market and media will be held in English at 09:00 CET, hosted by CEO Karl-Johan Persson, CFO Jyrki Tervonen and Head of Investor

Board Appointment

Board Appointment 15 March 2019  EnQuest PLC ('EnQuest') is pleased to announce its intention to appoint Howard Paver as a Non-Executive Director of the EnQuest Board with effect from 1 May 2019. On joining the Board, Howard Paver will become a member of the Remuneration and Audit Committees and stand for election at the Company's Annual General Meeting in May.Howard has 40 years' global experience in E&P and was previously SVP, strategy, commercial & business development at Hess. Jock Lennox, Chairman of EnQuest: "I am delighted to welcome Howard Paver to the Board of EnQuest.

Pileseptin is now available for sale at apotekhjem.no in Norway

Double Bond Pharmaceuticals subsidiary Drugsson AB, distributor of Pileseptin in the Nordic market, reports that Pileseptin in both gel and spray form is now available at apotekhjem.no in Norway. Earlier this year the product became available on Apotea, Apotek365 and Meds.se in Sweden. "We are happy to have our first non-prescription product on the market in Norway and work to establish deals with several other sales channels in the future," comments Igor Lokot, CEO at Double Bond Pharmaceutical and Drugsson AB, - We continue to look for new, sought-after products that may be of interest

Year-end report 2018

Mölndal, March 15, 2019 – Vicore Pharma Holding (publ) (ticker: VICO) publish the year-end report for 2018Important events during the fourth quarter ·  In October, Vicore announced that the rights issue completed in September was oversubscribed by 33% and raised approximately 82 MSEK ·  In October, Göran Wessman announced his resignation from the board of directors due to health reasons ·  In November, the board of directors decided to act for the company’s shares to be admitted for trading on the Nasdaq Stockholm’s main list in 2019 ·  In November, the board of directors

Neste Corporation's disposal of own shares based on the share ownership plan

Neste Corporation, Stock Exchange Release, 15 March 2019 at 9 am. (EET) A total of 56,033 treasury shares of Neste Corporation has been on the 15th of March 2019 conveyed without consideration to the key persons participating in the Share Ownership Plan 2016 according to the terms and conditions of the plan. The decision of the Board of Directors is based on a share issue authorization granted by the Annual General Meeting of Shareholders on 5th April 2018. A total of 84 people are in the target group of the payment from the plan. After the aforementioned share transfer

Pandox AB (publ) annual report for 2018 has been published

The Swedish version of Pandox ABs annual report for 2018 has been published on www.pandox.se.  The Swedish printed version of the annual report will be distributed to shareholders having so wished during week 13. The annual report can also be ordered at www.pandox.se or by phone+46 8 506 205 50.  The English version of the annual report is expected to be available within two weeks. FOR MORE INFORMATION, PLEASE CONTACT: Anders Berg, SVP Communications and IR, +46 (0) 760 95 19 40Caroline Tivéus, Director Sustainable Business, +46 (0) 735 32 74 41 This information is

Nokian Tyres’ Financial Review and Corporate Sustainability Report 2018 published

Nokian Tyres plc Stock Exchange Release March 15, 2019 at 9:00 a.m. Nokian Tyres has published its Financial Review 2018 at nokiantyres.com/company/investors/  and the Corporate Sustainability Report 2018 at nokiantyres.com/company/sustainability .  The Financial Review 2018 is published as a PDF version, and it includes the President and CEO’s review, the Report by the Board of Directors, the Financial statements, Auditors' report, Corporate Governance Statement and Remuneration

KONE to modernize elevators at 14 stations of Hong Kong’s Mass Transit Railway

KONE Corporation, press release, March 15, 2019KONE, a global leader in the elevator and escalator industry, has won an order to modernize the elevators at 14 metro stations of the MTR (Mass Transit System) system in Hong Kong, China.The MTR system includes 93 stations and 68 light rail stops and has an average weekday patronage of about 5.8 million passengers. KONE will supply 26 KONE MonoSpace® machine-room-less elevators to replace existing hydraulic passenger elevators at 14 stations of the transport network.“Hong Kong’s MTR system is widely considered as one of the best

Notice to convene Herantis Pharma Plc’s Annual General Meeting of shareholders

Notice to convene Herantis Pharma Plc’s Annual General Meeting of shareholders Herantis Pharma PlcCompany release 15 March 2019 at 9:00 am NOTICE TO CONVENE HERANTIS PHARMA PLC’S ANNUAL GENERAL MEETING OF SHAREHOLDERS Shareholders of Herantis Pharma Plc are invited to attend the Annual General Meeting of the Company on Thursday, April 11, 2019, commencing at 13.00 pm (EET) at Etera-talo, at the address Palkkatilanportti 1, Helsinki, Finland. The reception of participants and the distribution of voting tickets will commence, and coffee will be served, at 12.30 pm. A Matters on

Invitation to a Q&A teleconference with Outotec

OUTOTEC OYJ  PRESS RELEASE MARCH 15, 2019  9:00 AM Invitation to a Q&A teleconference with Outotec The Q&A teleconference with CEO Markku Teräsvasara will be held on Friday, March 22, 2019 at 2:00 PM (Finnish time). JOINING THE TELECONFERENCE AND PRESENTING QUESTIONS Dial in 5-10 minutes prior to the start time using the number below. Conference code: 26131918# FI: +358 981 710 310SE: +46 856 642 651UK: +44 333 300 08 04US: +1 631 913 14 22 Questions may be sent also in advance via email to riitta.lind(at)outotec.com by March 22 at 10:00 AM. The recording of the

H+H Annual Report 2018

H+H Annual Report 2018 “Strong organic growth in combination with good performance in the acquired businesses was the basis for the strong result in 2018”, says CEO Michael T. Andersen. “We pursue further M&A opportunities in Central Europe as we see a need for market restructuring and H+H is in a unique situation to participate in such.” Selected financial highlights for 2018    Q4 2018    Q4 2017  Q1-Q4 2018  Q1-Q4 2017Revenue 660 370 2,523 1,622Organic growth 30% 18%EBITDA before 110 61

Spring Getaway Specials at California Inns

SACRAMENTO, CA [March 14, 2019]—Bid farewell to winter with a getaway to California’s warm sunshine and spring blooms. Members of the California Association of Boutique and Breakfast Inns (CABBI) are offering an array of special deals this spring, ranging from discounted rates to savings on spa and outdoor packages. Some specials are listed below; many more specials can be found online at www.cabbi.com. Now through Memorial Day, Carmel Valley Lodge  is offering a Come Celebrate Spring package for $199 per person, plus a 20% discount on

Notice to attend Extraordinary General Meeting in MQ Holding AB

The shareholders of MQ Holding AB, company reg. no. 556697-2211, are hereby invited to an Extraordinary General Meeting to be held on Wednesday 24 April 2019 at 2.00 p.m. at the company’s premises on Sankt Eriksgatan 5, Gothenburg, Sweden. Entry starts at 1.30 p.m. Notice etc. Right to attend the general meeting is given to those who are entered as shareholders in the share register maintained by Euroclear Sweden AB on Tuesday 16 April 2019 and have given notice of their participation in the general meeting no later than Tuesday 16 April 2019, preferably before 4.00 p.m. A printed

Kværner ASA: Johan Sverdrup platform sets new completion standard

15 March 2019 - As the Johan Sverdrup Utility and Living Quarter platform is transported to the offshore field, it sets a new standard for how complete an installation can be before sail-away. The result is saved costs and shorter time before the production can start the flow of revenues to the licence owners and to the society. The platform is delivered by the joint venture of Kvaerner and KBR, and is delivered on schedule and on budget. Today, operator Equinor and the other licensees, KBR and Kvaerner celebrate the sailaway of the platform, with a symbolic release of the mooring lines

Intense quarter characterised by important measures

The market has remained cautious during the quarter with a high level of campaign activity. Lower interest in the winter sale had a major impact on the Group during the quarter, while the new collections were well received by our customers. The MQ Group has had a weak quarter in terms of sales and has also been affected by non-recurring costs for the structural action programme and by write-downs of intangible assets.   Second quarter (December 2018–February 2019)   ·  Net sales amounted to SEK 424 million (448), down 5.4 per cent. Like-for-like sales declined 5.0 per cent (

Comments on media reports

Late Thursday, 14 March 2019, Swedbank received information from Swedish Television’s TV program Uppdrag granskning. The analysis that Uppdrag granskning refers to is the initial report that Swedbank made last autumn, based on transactions between customers in Swedbank and customers in Danske Bank. Based on that report, additional activities have since been made.Swedbank takes its responsibilities to prevent and detect money laundering very seriously.  In 2018, Swedbank on its own initiative in response to public information regarding Danske Bank made an analysis of payments between

Targovax signs clinical collaboration agreement with the Parker Institute for Cancer Immunotherapy and Cancer Research Institute

· The parties plan to conduct a clinical collaboration trial with Targovax TG mutant RAS vaccine · The collaboration will focus on testing TG vaccination in combination with other treatments in late stage pancreatic cancer Oslo, Norway, 15 March 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces that it has entered into an agreement with The Parker Institute for Cancer Immunotherapy (PICI) and the Cancer Research Institute (CRI) for a clinical collaboration with Targovax’ TG mutant

Planmeca Viso™ product line of next-gen CBCT imaging units expands

Planmeca has introduced a new member to its growing Planmeca Viso™ product family of next generation imaging units. Combining innovative patient positioning, fantastic usability and outstanding image quality, the new Planmeca Viso™ G5 provides a cutting-edge CBCT imaging experience. From 2D imaging to the most demanding requirements for maxillofacial diagnostics, the new Planmeca Viso™ G5 CBCT unit offers outstanding features for all users and purposes. It is an ideal addition to the Planmeca Viso™ family and perfectly complements the full skull imaging unit Planmeca Viso™ G7, which was

Q-linea can reach its main market faster than planned

Q-linea AB (publ) (OMX: QLINEA), today announced that the company's first product ASTar™ is expected to launch on the company’s main market, the U.S., three to four months than earlier communicated to take advantage of strong market interest and positive feedback from the US Food and Drug Administration, the FDA. The European launch is thus postponed to the same extent.In Q-linea's discussions with potential sales partners, increasing emphasis has been placed on the US market. Against this background, and because of the positive feedback Q-linea received from the US Food and Drug

“LA REINA DEL SUR” SEASON TWO TRAILER BREAKS RECORD REACHING MORE THAN 8.0M VIEWS ACROSS DIGITAL PLATFORMS

Season Two Premieres on Telemundo on Monday, April 22 at 10pm/9c MIAMI – March 14, 2019 – “La Reina del Sur” Season Two trailer broke Telemundo’s record registering 8.1M views in its first week across all digital platforms including Instagram , Facebook , You tube  and Telemundo.com , according to Adobe Analytics and Shareablee.  The official trailer released last week offered fans a sneak peek of the action-packed return of “La

Stora Enso’s Annual General Meeting and decisions by the Board of Directors

STORA ENSO OYJ STOCK EXCHANGE RELEASE 14 March 2019 at 18:40 EETStora Enso’s Annual General Meeting (AGM) on 14 March 2019 adopted the accounts for 2018 and granted the Company’s Board of Directors and Chief Executive Officer discharge from liability for the period.Resolution on the use of the profit shown on the balance sheet and the payment of dividend The AGM approved the proposal by the Board of Directors that the Company distributes a dividend of EUR 0.50 per share for the year 2018.The dividend shall be paid to shareholders who on the record date of the dividend payment, Monday

Teleste's Annual Report 2018 and Financial Statements Published

TELESTE CORPORATION  STOCK EXCHANGE RELEASE    14.3.2019   AT 17:50  EET TELESTE'S ANNUAL REPORT AND FINANCIAL STATEMENTS PUBLISHED Teleste Corporation's Annual Report 2018 and financial statements for the accounting period 1 January - 31 December 2018 have been published in English and Finnish on the company's website. The Annual Report includes the financial statements, the Board of Directors'  report and the Auditors' report. A pdf-file of the Annual Report is attached to this release. Teleste has also published its Corporate Governance Statement 2018 together with the Annual

Share buy-back by Zalaris ASA

On 14 March 2019, Zalaris ASA purchased 51.528 own shares on the Oslo Stock Exchange at an average price of NOK 23,9857. Following the purchase Zalaris ASA holds 149,478 own shares, representing ~0.74% of the total outstanding shares. The shares were purchased in accordance with the share buy-back programme announced 12 March 2019, available at www.newsweb.no. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Dignitana CEO William Cronin to Speak at Aktiedagen Stockholm

Dignitana AB  announces that Chief Executive Officer William Cronin will speak at Aktiedagen Stockholm  on 19 March 2019 at 15:00 CET. The event is held at Operaterrassen, Karl XII Square, Stockholm. Admission is free, but those who wish to attend must contact event@aktiespararna.se to register. To access Dignitana’s 20-minute presentation live, please visit aktiepararna.se/tv/live  at the scheduled time. The presentation will be posted the following day on www.

There are no items matching the current filter
There are no more items matching the current filter
Back to top